<?xml version="1.0" encoding="UTF-8"?><faers xmlns="http://fda.gov/ns/faers"><meta><status>APPROVED</status><version>v2</version><patient-age>56</patient-age><report-id>PHFR2010IE05757</report-id><gender>unknown</gender><reactions><reaction>Swollen left arm</reaction><reaction>Drug reaction</reaction><reaction>Lymphoedema</reaction><reaction>Breast cancer/ multiple lung and liver metastases, bony metastases</reaction><reaction>Psychiatric complication</reaction><reaction>General deterioration</reaction><reaction>Patient apparently complained of being "sick with my nerves"</reaction><reaction>Immune compromised</reaction><reaction>Confusion</reaction><reaction>Dehydration</reaction><reaction>Extrapyramidal side effect</reaction><reaction>Physician wonder about catatonia</reaction><reaction>Physician wonder about neuroleptic malignant syndrome</reaction><reaction>Possible seizure like activity</reaction><reaction>physician wonder about sepsis</reaction><reaction>Body became very stiff and rigid</reaction><reaction>Became less responsive</reaction><reaction>Episode twitching all over</reaction><reaction>Generalized increased tone</reaction></reactions><drugs><drug><ndc>59572983</ndc><drug-name>CLOZARIL</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>INDERAL "IMPERIAL CHEMICAL INDUSTRIES"</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>DIAZEPAM</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>SULPIRIDE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>TRIFLUOPERAZINE</drug-name><manufacturer/><ingredients/></drug><drug><ndc>59572983</ndc><drug-name>QUETIAPIN</drug-name><manufacturer/><ingredients/></drug></drugs><indications><indication>Schizophrenia</indication><indication>Psychotic disorder</indication></indications><outcomes><outcome>Required Inpatient Hospitalization</outcome></outcomes><country>Ireland</country><geo/></meta><original><ichicsr lang="en" xmlns="">
	<ichicsrmessageheader>
		<messagetype>ichicsr</messagetype>
		<messageformatversion>2.1</messageformatversion>
		<messageformatrelease>2.0</messageformatrelease>
		<messagenumb>4053100_286</messagenumb>
		<messagesenderidentifier>NovartisPH</messagesenderidentifier>
		<messagereceiveridentifier>ZZFDA</messagereceiveridentifier>
		<messagedateformat>204</messagedateformat>
		<messagedate>20121211133612</messagedate>
	</ichicsrmessageheader>
	<safetyreport>
		<safetyreportversion>4</safetyreportversion>
		<safetyreportid>PHFR2010IE05757</safetyreportid>
		<primarysourcecountry>IE</primarysourcecountry>
		<occurcountry>IE</occurcountry>
		<transmissiondateformat>102</transmissiondateformat>
		<transmissiondate>2012-12-11</transmissiondate>
		<reporttype>1</reporttype>
		<serious code="1">Yes</serious>
		<seriousnessdeath>2</seriousnessdeath>
		<seriousnesslifethreatening>2</seriousnesslifethreatening>
		<seriousnesshospitalization>1</seriousnesshospitalization>
		<seriousnessdisabling>2</seriousnessdisabling>
		<seriousnesscongenitalanomali>2</seriousnesscongenitalanomali>
		<seriousnessother>1</seriousnessother>
		<receivedateformat>102</receivedateformat>
		<receivedate>2010-12-07</receivedate>
		<receiptdateformat>102</receiptdateformat>
		<receiptdate>2012-12-03</receiptdate>
		<additionaldocument>2</additionaldocument>
		<fulfillexpeditecriteria>1</fulfillexpeditecriteria>
		<companynumb>PHFR2010IE05757</companynumb>
		<medicallyconfirm>1</medicallyconfirm>
		<linkedreport>
			<linkreportnumb>PHFR2011IE02275</linkreportnumb>
		</linkedreport>
		<primarysource>
			<reportertitle>Dr</reportertitle>
			<reportergivename>John</reportergivename>
			<reporterfamilyname>Barton</reporterfamilyname>
			<reportercountry>IE</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>IE</reportercountry>
			<qualification code="3">Other Health Professional</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>IE</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>IE</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>IE</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<primarysource>
			<reporterfamilyname>PRIVACY</reporterfamilyname>
			<reportercountry>IE</reportercountry>
			<qualification code="1">Physician</qualification>
		</primarysource>
		<sender>
			<sendertype>1</sendertype>
			<senderorganization>NOVARTIS PHARMACEUTICAL CORPORATION</senderorganization>
			<senderdepartment>Clinical Safety and Epidemiology</senderdepartment>
			<senderfamilyname>Clinical Safety and Epidemiology</senderfamilyname>
			<senderstreetaddress>Novartis Pharmaceuticals Corp. Bldg 419, One Health Plaza</senderstreetaddress>
			<sendercity>East Hanover</sendercity>
			<senderstate>NJ</senderstate>
			<senderpostcode>07936</senderpostcode>
			<sendercountrycode>US</sendercountrycode>
			<sendertel>+1800378</sendertel>
			<sendertelextension>8567</sendertelextension>
			<sendertelcountrycode>US</sendertelcountrycode>
			<senderfax>+1973781</senderfax>
			<senderfaxextension>8001</senderfaxextension>
			<senderfaxcountrycode>US</senderfaxcountrycode>
			<senderemailaddress>gdss.configuration@pharma.novartis.com</senderemailaddress>
		</sender>
		<receiver>
			<receivertype>2</receivertype>
			<receiverorganization>ZZFDA</receiverorganization>
			<receiverdepartment>FDA</receiverdepartment>
			<receivertitle>Mr</receivertitle>
			<receivergivename>William</receivergivename>
			<receiverfamilyname>Taylor</receiverfamilyname>
			<receiverstreetaddress>5600 Fishers Lane Room 16B-45</receiverstreetaddress>
			<receivercity>Rockville</receivercity>
			<receiverstate>MD</receiverstate>
			<receiverpostcode>20857</receiverpostcode>
			<receivercountrycode>US</receivercountrycode>
			<receivertel>+1301827</receivertel>
			<receivertelextension>0964</receivertelextension>
			<receivertelcountrycode>US</receivertelcountrycode>
			<receiverfax>+1301594</receiverfax>
			<receiverfaxextension>0829</receiverfaxextension>
			<receiverfaxcountrycode>US</receiverfaxcountrycode>
			<receiveremailaddress>.</receiveremailaddress>
		</receiver>
		<patient>
			<patientinitial>PC</patientinitial>
			<patientinvestigationnumb>291382</patientinvestigationnumb>
			<patientbirthdateformat>102</patientbirthdateformat>
			<patientbirthdate>19540628</patientbirthdate>
			<patientsex code="2">Female</patientsex>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Breast cancer recurrent</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Postmenopause</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Partial lung resection</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20030911</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Lymphadenectomy</patientepisodename>
				<patientmedicalstartdateformat>102</patientmedicalstartdateformat>
				<patientmedicalstartdate>20030911</patientmedicalstartdate>
				<patientmedicalcontinue>3</patientmedicalcontinue>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Treatment noncompliance</patientepisodename>
			</medicalhistoryepisode>
			<medicalhistoryepisode>
				<patientepisodenamemeddraversion>15.1</patientepisodenamemeddraversion>
				<patientepisodename>Radiotherapy</patientepisodename>
				<patientmedicalcomment>Radiotherapy between Apr 2004 and May 2004 / Palliative radiotherapy and as per comment on letter of</patientmedicalcomment>
			</medicalhistoryepisode>
			<reaction>
				<primarysourcereaction>Swollen left arm</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Swollen arm</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Oedema peripheral</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Drug reaction</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Adverse drug reaction</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Adverse drug reaction</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Lymphoedema</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Lymphoedema</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Lymphoedema</reactionmeddrapt>
				<reactionoutcome code="3">not recovered/not resolved</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Breast cancer/ multiple lung and liver metastases, bony metastases</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Breast cancer metastatic</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Breast cancer metastatic</reactionmeddrapt>
				<reactionstartdateformat>102</reactionstartdateformat>
				<reactionstartdate>20030902</reactionstartdate>
				<reactionfirsttime>1003</reactionfirsttime>
				<reactionfirsttimeunit>804</reactionfirsttimeunit>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Psychiatric complication</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Psychiatric symptom</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Psychiatric symptom</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>General deterioration</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>General physical health deterioration</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>General physical health deterioration</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Patient apparently complained of being "sick with my nerves"</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Neurologic disorder NOS</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Nervous system disorder</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Immune compromised</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Immune system disorder</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Immune system disorder</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Confusion</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Confusion</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Confusional state</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Dehydration</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Dehydration</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Dehydration</reactionmeddrapt>
				<termhighlighted>3</termhighlighted>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Extrapyramidal side effect</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Extrapyramidal symptoms</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Extrapyramidal disorder</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Physician wonder about catatonia</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Catatonia</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Catatonia</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Physician wonder about neuroleptic malignant syndrome</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Neuroleptic malignant syndrome</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Neuroleptic malignant syndrome</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Possible seizure like activity</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Seizure</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Convulsion</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>physician wonder about sepsis</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Sepsis</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Sepsis</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Body became very stiff and rigid</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Stiffness</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Musculoskeletal stiffness</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Body became very stiff and rigid</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Rigidity</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Muscle rigidity</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Became less responsive</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Responses voluntary reduced</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Hypokinesia</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Episode twitching all over</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Twitching</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Muscle twitching</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<reaction>
				<primarysourcereaction>Generalized increased tone</primarysourcereaction>
				<reactionmeddraversionllt>15.1</reactionmeddraversionllt>
				<reactionmeddrallt>Tone increased</reactionmeddrallt>
				<reactionmeddraversionpt>15.1</reactionmeddraversionpt>
				<reactionmeddrapt>Hypertonia</reactionmeddrapt>
				<reactionoutcome code="6">unknown</reactionoutcome>
			</reaction>
			<test>
				<testdateformat>610</testdateformat>
				<testdate>201104</testdate>
				<testname>Bone scan</testname>
				<moreinformation>1</moreinformation>
			</test>
			<test>
				<testname>Coma scale</testname>
				<moreinformation>2</moreinformation>
			</test>
			<drug>
				<drugcharacterization code="1">suspsect</drugcharacterization>
				<medicinalproduct>CLOZARIL</medicinalproduct>
				<obtaindrugcountry>IE</obtaindrugcountry>
				<drugauthorizationnumb>19-758</drugauthorizationnumb>
				<drugauthorizationcountry>IE</drugauthorizationcountry>
				<drugauthorizationholder>NOVARTIS SECTOR: PHARMA</drugauthorizationholder>
				<drugstructuredosagenumb>250</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>250 mg, BID</drugdosagetext>
				<drugdosageform normalized="tablet">Tablet</drugdosageform>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Schizophrenia</drugindication>
				<drugstartdateformat>102</drugstartdateformat>
				<drugstartdate>2000-12-04</drugstartdate>
				<actiondrug code="1">Drug Withdrawn</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>CLOZAPINE</activesubstancename>
				</activesubstance>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Adverse drug reaction</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Adverse drug reaction</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Breast cancer metastatic</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Breast cancer metastatic</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Catatonia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Catatonia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Confusional state</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Confusional state</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Convulsion</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Convulsion</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dehydration</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Dehydration</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Extrapyramidal disorder</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Extrapyramidal disorder</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>General physical health deterioration</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>General physical health deterioration</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypertonia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypertonia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypokinesia</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Hypokinesia</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Immune system disorder</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Immune system disorder</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Lymphoedema</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Lymphoedema</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Muscle rigidity</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Muscle rigidity</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Muscle twitching</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Muscle twitching</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Musculoskeletal stiffness</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Musculoskeletal stiffness</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Nervous system disorder</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Nervous system disorder</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Neuroleptic malignant syndrome</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Neuroleptic malignant syndrome</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Oedema peripheral</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Oedema peripheral</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Psychiatric symptom</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Psychiatric symptom</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Sepsis</drugreactionasses>
					<drugassessmentsource>PHARMACEUTICAL COMPANY</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Not assessable</drugresult>
				</drugreactionrelatedness>
				<drugreactionrelatedness>
					<drugreactionassesmeddraversion>15.1</drugreactionassesmeddraversion>
					<drugreactionasses>Sepsis</drugreactionasses>
					<drugassessmentsource>PRIMARY SOURCE REPORTER</drugassessmentsource>
					<drugassessmentmethod>Global Introspection</drugassessmentmethod>
					<drugresult>Suspected</drugresult>
				</drugreactionrelatedness>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>INDERAL "IMPERIAL CHEMICAL INDUSTRIES"</medicinalproduct>
				<obtaindrugcountry>IE</obtaindrugcountry>
				<drugauthorizationcountry>IE</drugauthorizationcountry>
				<drugstructuredosagenumb>10</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>10 mg, BID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="4">Dose not changed</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>PROPRANOLOL HYDROCHLORIDE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>DIAZEPAM</medicinalproduct>
				<obtaindrugcountry>IE</obtaindrugcountry>
				<drugauthorizationcountry>IE</drugauthorizationcountry>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>5 m, BID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>DIAZEPAM</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>SULPIRIDE</medicinalproduct>
				<obtaindrugcountry>IE</obtaindrugcountry>
				<drugauthorizationcountry>IE</drugauthorizationcountry>
				<drugstructuredosagenumb>100</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>3</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>100 mg, TID</drugdosagetext>
				<drugadministrationroute code="048">Oral</drugadministrationroute>
				<drugindicationmeddraversion>15.1</drugindicationmeddraversion>
				<drugindication>Psychotic disorder</drugindication>
				<actiondrug code="4">Dose not changed</actiondrug>
				<activesubstance>
					<activesubstancename>SULPIRIDE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>TRIFLUOPERAZINE</medicinalproduct>
				<obtaindrugcountry>IE</obtaindrugcountry>
				<drugauthorizationcountry>IE</drugauthorizationcountry>
				<drugstructuredosagenumb>5</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>5 mg, BID</drugdosagetext>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>TRIFLUOPERAZINE</activesubstancename>
				</activesubstance>
			</drug>
			<drug>
				<drugcharacterization code="2">concomitant</drugcharacterization>
				<medicinalproduct>QUETIAPIN</medicinalproduct>
				<obtaindrugcountry>IE</obtaindrugcountry>
				<drugauthorizationcountry>IE</drugauthorizationcountry>
				<drugstructuredosagenumb>200</drugstructuredosagenumb>
				<drugstructuredosageunit code="003">milligrams</drugstructuredosageunit>
				<drugseparatedosagenumb>2</drugseparatedosagenumb>
				<drugintervaldosageunitnumb>1</drugintervaldosageunitnumb>
				<drugintervaldosagedefinition code="804">Day</drugintervaldosagedefinition>
				<drugdosagetext>200 mg, BID</drugdosagetext>
				<actiondrug code="5">Unknown</actiondrug>
				<drugrecurreadministration code="3">Unknown</drugrecurreadministration>
				<activesubstance>
					<activesubstancename>QUETIAPINE FUMARATE</activesubstancename>
				</activesubstance>
			</drug>
			<summary>
				<narrativeincludeclinical><Semaphore x="1938518" class="Disease or Finding" value="First-Degree Burn" score="1.00" ID="C76130">Initial </Semaphore>serious spontaneous report received from a <Semaphore x="1642550" class="Procedure" value="Breast Feels Heavy" score="1.00" ID="C105748">nurse </Semaphore>via a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 07 Dec 2010. The patient (CPMS No 291382) commenced on <Semaphore x="385527" class="Medicine" value="Clozaril" score="0.97" ID="247865">Clozaril </Semaphore>(<Semaphore x="385490" class="Medicine" value="Clozapine" score="0.49" ID="252210">clozapine</Semaphore>) on 04 Dec 2000 for <Semaphore x="2499616" class="Disease or Finding" value="Schizophrenia" score="1.00" ID="C3362">schizophrenia</Semaphore>. On an unknown date, the patient had a <Semaphore x="3149857" class="MedDRA LLT" value="Oedema peripheral" score="1.00" ID="10030124">swollen <Semaphore x="1543524" class="AnatomicStructure" value="Arm" score="1.00" ID="C32141">left arm </Semaphore></Semaphore>over weekend and saw GP on 06 Dec 2010 and was later admitted to the hospital. <Semaphore x="2352492" class="Disease or Finding" value="Other Finding" score="0.58" ID="C36295">Outcome </Semaphore>and causality were not provided.Follow up received from <Semaphore x="2457592" class="Occupation" value="Registrar" score="1.00" ID="C25357">registrar </Semaphore>(<Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician</Semaphore>) on 26 May 2011: The patient received <Semaphore x="385527" class="Medicine" value="Clozaril" score="0.97" ID="247865">Clozaril </Semaphore>with a dose of 250 mg twice daily from an unknown date. The patient had a history <Semaphore x="1637909" class="Disease or Finding" value="Breast Carcinoma" score="1.00" ID="C4872">of <Semaphore x="2453473" class="Disease or Finding" value="Recurrent Malignant Neoplasm" score="1.00" ID="C4813">recurrence </Semaphore>of <Semaphore x="2826913" class="MedDRA LLT" value="Breast cancer" score="1.00" ID="10006187"><Semaphore x="1593217" class="Procedure" value="Biopsy of Breast" score="1.00" ID="C51698">breast </Semaphore>cancer </Semaphore></Semaphore>which was reported to be ongoing at the time of this report. On an unknown date the patient presented with a <Semaphore x="3149857" class="MedDRA LLT" value="Oedema peripheral" score="1.00" ID="10030124">swollen <Semaphore x="1543524" class="AnatomicStructure" value="Arm" score="1.00" ID="C32141">arm</Semaphore></Semaphore>, which was initially believed to be a <Semaphore x="2453473" class="Disease or Finding" value="Recurrent Malignant Neoplasm" score="1.00" ID="C4813">recurrence </Semaphore><Semaphore x="1637909" class="Disease or Finding" value="Breast Carcinoma" score="1.00" ID="C4872">of <Semaphore x="2826913" class="MedDRA LLT" value="Breast cancer" score="1.00" ID="10006187"><Semaphore x="1593217" class="Procedure" value="Biopsy of Breast" score="1.00" ID="C51698">breast </Semaphore>cancer </Semaphore></Semaphore>but was subsequently found to be a <Semaphore x="2138268" class="Disease or Finding" value="Lymphedema" score="1.00" ID="C3207">lymphedema</Semaphore>. At the time of report the <Semaphore x="2352492" class="Disease or Finding" value="Other Finding" score="0.58" ID="C36295">outcome </Semaphore>of <Semaphore x="3081011" class="MedDRA LLT" value="Lymphoedema" score="1.00" ID="10025282">lymphoedema </Semaphore>was unknown. The patient was undergoing further oncology attention at the time of report. The patient's <Semaphore x="3149857" class="MedDRA LLT" value="Oedema peripheral" score="1.00" ID="10030124">swollen <Semaphore x="1543524" class="AnatomicStructure" value="Arm" score="1.00" ID="C32141">arm </Semaphore></Semaphore>and <Semaphore x="2453473" class="Disease or Finding" value="Recurrent Malignant Neoplasm" score="1.00" ID="C4813">recurrence </Semaphore><Semaphore x="1637909" class="Disease or Finding" value="Breast Carcinoma" score="1.00" ID="C4872">of <Semaphore x="2826913" class="MedDRA LLT" value="Breast cancer" score="1.00" ID="10006187"><Semaphore x="1593217" class="Procedure" value="Biopsy of Breast" score="1.00" ID="C51698">breast </Semaphore>cancer </Semaphore></Semaphore>were not considered to be causally related to <Semaphore x="385527" class="Medicine" value="Clozaril" score="0.97" ID="247865">Clozaril </Semaphore><Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">therapy</Semaphore>.Follow up information was received from a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 15 Jun 2011: The reporter confirmed that patient was still undergoing <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>with oncology. The reporter was not <Semaphore x="1748012" class="Procedure" value="Certainty that Good Outweighs the Bad Things About Medication" score="1.00" ID="C107551">sure </Semaphore>if the patient's history <Semaphore x="1637909" class="Disease or Finding" value="Breast Carcinoma" score="1.00" ID="C4872">of <Semaphore x="2826913" class="MedDRA LLT" value="Breast cancer" score="1.00" ID="10006187"><Semaphore x="1593217" class="Procedure" value="Biopsy of Breast" score="1.00" ID="C51698">breast </Semaphore>cancer </Semaphore></Semaphore>was subsequently discovered as <Semaphore x="3081011" class="MedDRA LLT" value="Lymphoedema" score="1.00" ID="10025282">lymphoedema</Semaphore>. No further information was provided.Follow up information received from a <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 13 Oct 2011: The reporter confirmed that this was a hospital <Semaphore x="1675087" class="Disease or Finding" value="Cant" score="1.00" ID="C82117">based </Semaphore><Semaphore x="1670730" class="Procedure" value="CAM Pharmacological or Biological Treatment" score="1.00" ID="C15906">drug </Semaphore>reaction. The reporter had no information apart from verbal information of the incident. <Semaphore x="1802982" class="Disease or Finding" value="Communication Disorder" score="1.00" ID="C2958">Contacts </Semaphore>details of hospital was provided.Follow up information received from <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>on 03 Dec 2012: The concomitant medication was reported as <Semaphore x="1237841" class="Medicine - Sulpiride - Dose" value="100 mg" score="0.49" ID=""><Semaphore x="1237882" class="Medicine" value="Sulpiride" score="0.49" ID="187164">sulpiride </Semaphore>(unknown <Semaphore x="2199623" class="Occupation" value="Manufacturer" score="1.00" ID="C25392">manufacturer</Semaphore>) <Semaphore x="5316486612647937" class="Medicine - Sulpiride - Dose" value="100 mg" score="0.49" ID="">100 mg </Semaphore></Semaphore>TDS and Steladine (<Semaphore x="1295674" class="Medicine - Trifluoperazine - Dose" value="5 mg" score="0.49" ID=""><Semaphore x="1295713" class="Medicine" value="Trifluoperazine" score="0.49" ID="191261">trifluoperazine</Semaphore>) <Semaphore x="5564877456277505" class="Medicine - Trifluoperazine - Dose" value="5 mg" score="0.49" ID="">5 mg </Semaphore></Semaphore><Semaphore x="5564959060656129" class="Medicine - Trifluoperazine - Frequency" value="BD" score="0.49" ID="">BD</Semaphore>. <Semaphore x="1637909" class="Disease or Finding" value="Breast Carcinoma" score="1.00" ID="C4872">The patient <Semaphore x="1846062" class="Procedure" value="Diagnosis" score="1.00" ID="C15220">diagnosed </Semaphore><Semaphore x="1637909" class="Disease or Finding" value="Breast Carcinoma" score="1.00" ID="C4872">of <Semaphore x="2826913" class="MedDRA LLT" value="Breast cancer" score="1.00" ID="10006187"><Semaphore x="1593217" class="Procedure" value="Biopsy of Breast" score="1.00" ID="C51698">breast </Semaphore>cancer </Semaphore></Semaphore></Semaphore>on 02 Sep 2003. As a <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment</Semaphore>, the patient had left <Semaphore x="2503896" class="Procedure" value="Segmentectomy" score="1.00" ID="C91061">segmentectomy </Semaphore>and <Semaphore x="1559833" class="Procedure" value="Axillary Lymph Node Dissection without Prior Sentinel Lymph Node Biopsy" score="1.00" ID="C105784">axillary dissection </Semaphore>on 11 Sep 2003. In the between 27 Nov 2003 and 10 Mar 2004, patient had 8 cycle accelerated <Semaphore x="1416086" class="Procedure" value="Activated Coagulation Time" score="1.00" ID="C103348">ACT</Semaphore>. The patient received <Semaphore x="2442569" class="Procedure" value="Radiation Therapy" score="1.00" ID="C15313">radiation therapy </Semaphore>between Apr 2004 and May 2004, and was also in astrozole (unknown <Semaphore x="2199623" class="Occupation" value="Manufacturer" score="1.00" ID="C25392">manufacturer</Semaphore>) 1mg OD. On an unspecified date in Apr 2011, <Semaphore x="1619584" class="AnatomicStructure" value="Bone" score="1.00" ID="C12366">bone </Semaphore><Semaphore x="2444079" class="Procedure" value="Radionuclide Imaging" score="1.00" ID="C62667">scan </Semaphore>revealed, new radio isotope uptake and reported as suspicious for <Semaphore x="3107233" class="MedDRA LLT" value="Metastases to bone" score="1.00" ID="10027452">bony <Semaphore x="3108419" class="MedDRA LLT" value="Metastasis" score="1.00" ID="10062194">metastases</Semaphore></Semaphore>. In May 2011, the patient had development of multiple <Semaphore x="3107567" class="MedDRA LLT" value="Metastases to lung" score="1.00" ID="10027458"><Semaphore x="2224180" class="Disease or Finding" value="Metastatic Malignant Neoplasm" score="0.58" ID="C36263"><Semaphore x="2223072" class="Disease or Finding" value="Metastatic Malignant Neoplasm to the Lung" score="1.00" ID="C3577"><Semaphore x="2133397" class="AnatomicStructure" value="Lung" score="1.00" ID="C12468">lung </Semaphore>and <Semaphore x="3107530" class="MedDRA LLT" value="Metastases to liver" score="1.00" ID="10027457"><Semaphore x="2224180" class="Disease or Finding" value="Metastatic Malignant Neoplasm" score="0.58" ID="C36263"><Semaphore x="2223048" class="Disease or Finding" value="Metastatic Malignant Neoplasm to the Liver" score="1.00" ID="C4758">liver <Semaphore x="3108419" class="MedDRA LLT" value="Metastasis" score="1.00" ID="10062194">metastases</Semaphore></Semaphore>
         </Semaphore>
        </Semaphore>
       </Semaphore>
      </Semaphore>
     </Semaphore>
    <Semaphore x="3107233" class="MedDRA LLT" value="Metastases to bone" score="1.00" ID="10027452">, <Semaphore x="3107233" class="MedDRA LLT" value="Metastases to bone" score="1.00" ID="10027452">bony </Semaphore><Semaphore x="3108419" class="MedDRA LLT" value="Metastasis" score="1.00" ID="10062194">metastases </Semaphore></Semaphore>
    <Semaphore x="3107530" class="MedDRA LLT" value="Metastases to liver" score="1.00" ID="10027457">
     <Semaphore x="2224180" class="Disease or Finding" value="Metastatic Malignant Neoplasm" score="0.58" ID="C36263">
      <Semaphore x="2223048" class="Disease or Finding" value="Metastatic Malignant Neoplasm to the Liver" score="1.00" ID="C4758">and <Semaphore x="2117991" class="Procedure" value="Liver Biopsy" score="1.00" ID="C51677">liver </Semaphore></Semaphore>
      <Semaphore x="2786196" class="MedDRA LLT" value="Biopsy liver" score="1.00" ID="10004791">
       </Semaphore></Semaphore>
     <Semaphore x="2786196" class="MedDRA LLT" value="Biopsy liver" score="1.00" ID="10004791">
      </Semaphore></Semaphore>
    <Semaphore x="2786196" class="MedDRA LLT" value="Biopsy liver" score="1.00" ID="10004791">
     <Semaphore x="1593217" class="Procedure" value="Biopsy of Breast" score="1.00" ID="C51698">biopsy </Semaphore>
     <Semaphore x="2784743" class="MedDRA LLT" value="Biopsy breast" score="1.00" ID="10004744">
      <Semaphore x="1645054" class="AnatomicStructure" value="Breast" score="1.00" ID="C12971">
       <Semaphore x="1593246" class="Procedure" value="Biopsy of Colon" score="1.00" ID="C51678">
        </Semaphore></Semaphore></Semaphore></Semaphore>
    <Semaphore x="2784743" class="MedDRA LLT" value="Biopsy breast" score="1.00" ID="10004744">
     <Semaphore x="1645054" class="AnatomicStructure" value="Breast" score="1.00" ID="C12971">
      <Semaphore x="1593246" class="Procedure" value="Biopsy of Colon" score="1.00" ID="C51678">
       <Semaphore x="1593217" class="Procedure" value="Biopsy of Breast" score="1.00" ID="C51698">revealed <Semaphore x="2221866" class="Disease or Finding" value="Metastatic Carcinoma" score="1.00" ID="C3482">metastatic <Semaphore x="1593217" class="Procedure" value="Biopsy of Breast" score="1.00" ID="C51698">breast </Semaphore></Semaphore></Semaphore>
       <Semaphore x="3108602" class="MedDRA LLT" value="Metastatic neoplasm" score="1.00" ID="10061289">
        <Semaphore x="2577306" class="Disease or Finding" value="Stage IV Breast Cancer" score="1.00" ID="C3995">
         <Semaphore x="2224180" class="Disease or Finding" value="Metastatic Malignant Neoplasm" score="0.58" ID="C36263">
          <Semaphore x="2221866" class="Disease or Finding" value="Metastatic Carcinoma" score="1.00" ID="C3482">
           </Semaphore></Semaphore></Semaphore></Semaphore></Semaphore>
      <Semaphore x="3108602" class="MedDRA LLT" value="Metastatic neoplasm" score="1.00" ID="10061289">
       <Semaphore x="2577306" class="Disease or Finding" value="Stage IV Breast Cancer" score="1.00" ID="C3995">
        <Semaphore x="2224180" class="Disease or Finding" value="Metastatic Malignant Neoplasm" score="0.58" ID="C36263">
         <Semaphore x="2221866" class="Disease or Finding" value="Metastatic Carcinoma" score="1.00" ID="C3482">
          </Semaphore></Semaphore></Semaphore></Semaphore></Semaphore>
     <Semaphore x="3108602" class="MedDRA LLT" value="Metastatic neoplasm" score="1.00" ID="10061289">
      <Semaphore x="2577306" class="Disease or Finding" value="Stage IV Breast Cancer" score="1.00" ID="C3995">
       <Semaphore x="2224180" class="Disease or Finding" value="Metastatic Malignant Neoplasm" score="0.58" ID="C36263">
        <Semaphore x="2221866" class="Disease or Finding" value="Metastatic Carcinoma" score="1.00" ID="C3482">
         </Semaphore></Semaphore></Semaphore></Semaphore></Semaphore>
    <Semaphore x="3108602" class="MedDRA LLT" value="Metastatic neoplasm" score="1.00" ID="10061289">
     <Semaphore x="2577306" class="Disease or Finding" value="Stage IV Breast Cancer" score="1.00" ID="C3995">
      <Semaphore x="2224180" class="Disease or Finding" value="Metastatic Malignant Neoplasm" score="0.58" ID="C36263">
       <Semaphore x="2221866" class="Disease or Finding" value="Metastatic Carcinoma" score="1.00" ID="C3482">
        <Semaphore x="2826913" class="MedDRA LLT" value="Breast cancer" score="1.00" ID="10006187">carcinoma</Semaphore></Semaphore></Semaphore></Semaphore></Semaphore>. The patient received zolendronic <Semaphore x="2147465" class="Procedure" value="Lysergide Measurement" score="1.00" ID="C75354">acid </Semaphore>(unknown <Semaphore x="2199623" class="Occupation" value="Manufacturer" score="1.00" ID="C25392">manufacturer</Semaphore>) IV every six month from 1 May 2011. The patient had <Semaphore x="972590" class="Medicine" value="Paclitaxel" score="0.49" ID="271916">paclitaxel </Semaphore>(unknown <Semaphore x="2199623" class="Occupation" value="Manufacturer" score="1.00" ID="C25392">manufacturer</Semaphore>) from 9 Jun 2011 which discontinued on 16 Jun 2011 due to psychiatric <Semaphore x="1804525" class="Disease or Finding" value="Complication" score="1.00" ID="C2959">complication </Semaphore>and general deterioration. On an unknown date (reported as few days before hospital admission) patient apparently complained of being "<Semaphore x="2520622" class="Disease or Finding" value="Sickness" score="1.00" ID="C107499">sick </Semaphore>with my <Semaphore x="2294741" class="Disease or Finding" value="Nerve Paralysis" score="1.00" ID="C27036">nerves</Semaphore>". The <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>call to CPMS in England which advised that <Semaphore x="385527" class="Medicine" value="Clozaril" score="0.97" ID="247865">Clozaril </Semaphore>should not recommenced, as patient was more immune compromised and Quetipine (<Semaphore x="1115130" class="Medicine - QUEtiapine fumarate - Dose" value="200 mg" score="0.49" ID=""><Semaphore x="1115157" class="Medicine" value="QUEtiapine fumarate" score="0.49" ID="249169">quetiapine fumarate</Semaphore>) <Semaphore x="4789446880788481" class="Medicine - QUEtiapine fumarate - Dose" value="200 mg" score="0.49" ID="">200 mg </Semaphore></Semaphore><Semaphore x="4789502715363329" class="Medicine - QUEtiapine fumarate - Frequency" value="BD" score="0.49" ID="">BD </Semaphore>was commenced. The dose of <Semaphore x="385527" class="Medicine" value="Clozaril" score="0.97" ID="247865">Clozaril </Semaphore>before hospital was reported as 250 mg. On 18 Jun 2011, the patient was admitted in hospital with <Semaphore x="1806199" class="Disease or Finding" value="Confusion" score="1.00" ID="C37928">confusion </Semaphore>and <Semaphore x="1839429" class="Disease or Finding" value="Dehydration Polycythemia" score="1.00" ID="C27310">dehydration</Semaphore>. On 20 Jun 2011, the patient had episode <Semaphore x="2659026" class="Disease or Finding" value="Twitching" score="1.00" ID="C50785">twitching </Semaphore>all over and became less responsive. The <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>notes that, patient <Semaphore x="1610517" class="AnatomicStructure" value="Body" score="1.00" ID="C13041">body </Semaphore>became very stiff and rigid and patient refused to take any further medication. Examination revealed that, Glasgow <Semaphore x="1801434" class="Disease or Finding" value="Coma" score="1.00" ID="C34497">coma </Semaphore>score 13/15 and generalized <Semaphore x="3019384" class="MedDRA LLT" value="Hypertonia" score="1.00" ID="10020852">increased tone</Semaphore>. The <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>thought that, patient had extrapyramidal <Semaphore x="2520673" class="Disease or Finding" value="Side Effect" score="1.00" ID="C2861">side effect </Semaphore>relating to antipsychotic <Semaphore x="2610768" class="Procedure" value="Therapeutic Procedure" score="1.00" ID="C49236">treatment </Semaphore>and was wondered about <Semaphore x="2845750" class="MedDRA LLT" value="Catatonia" score="1.00" ID="10007776">catatonia </Semaphore>and <Semaphore x="2305823" class="Disease or Finding" value="Neuroleptic Malignant Syndrome" score="1.00" ID="C94829">neuroleptic malignant syndrome</Semaphore>. On couple of occasion, on an unspecified date, the patient was presented with possible <Semaphore x="1936750" class="Procedure" value="Findings-Based Question" score="0.68" ID="C91103">seizure </Semaphore>like <Semaphore x="1416795" class="Disease or Finding" value="Active Caries" score="1.00" ID="C60712">activity </Semaphore>and was given <Semaphore x="798441" class="Medicine" value="LORazepam" score="0.49" ID="278517">Lorazepam </Semaphore>(unknown <Semaphore x="2199623" class="Occupation" value="Manufacturer" score="1.00" ID="C25392">manufacturer</Semaphore>). The <Semaphore x="2398439" class="Occupation" value="Physician" score="1.00" ID="C25741">physician </Semaphore>also reported to wonder about <Semaphore x="3245054" class="MedDRA LLT" value="Sepsis" score="1.00" ID="10040047">sepsis</Semaphore>. The note on 26 Jun 2011 revealed that, the patient <Semaphore x="1936750" class="Procedure" value="Findings-Based Question" score="0.68" ID="C91103">was doing well </Semaphore>and should continue with <Semaphore x="1824302" class="Procedure" value="Current Therapy" score="1.00" ID="C85582">current therapy</Semaphore>. On an unspecified date in Oct 2011, patient commenced on <Semaphore x="2366939" class="Procedure" value="Palliative Therapy" score="1.00" ID="C15292">palliative <Semaphore x="1884852" class="Procedure" value="Endocrine Therapy" score="1.00" ID="C15445">hormonal therapy </Semaphore></Semaphore>in the form of <Semaphore x="605077" class="Medicine - fulvestrant - Dose" value="500 mg" score="0.49" ID=""><Semaphore x="605106" class="Medicine" value="fulvestrant" score="0.49" ID="252373">fulvestrant </Semaphore>(unknown <Semaphore x="2199623" class="Occupation" value="Manufacturer" score="1.00" ID="C25392">manufacturer</Semaphore>) <Semaphore x="2598785926561793" class="Medicine - fulvestrant - Dose" value="500 mg" score="0.49" ID="">500 mg </Semaphore></Semaphore>IM every four weeks. On an unknown date, (comment on letter of 18 Jan 2012), the patient had palliative <Semaphore x="2442569" class="Procedure" value="Radiation Therapy" score="1.00" ID="C15313">radiotherapy </Semaphore>to the right hemi <Semaphore x="2383651" class="AnatomicStructure" value="Pelvis" score="1.00" ID="C12767">pelvis </Semaphore>one fraction of 80 <Semaphore x="1994909" class="AnatomicStructure" value="Gray Commissure" score="1.00" ID="C32694">gray</Semaphore>. The seriousness of event <Semaphore x="1806199" class="Disease or Finding" value="Confusion" score="1.00" ID="C37928">confusion </Semaphore>and <Semaphore x="1839429" class="Disease or Finding" value="Dehydration Polycythemia" score="1.00" ID="C27310">dehydration </Semaphore>was <Semaphore x="3012166" class="MedDRA LLT" value="Hospitalisation" score="1.00" ID="10054112">hospitalization</Semaphore>, and seriousness for other event was not reported. The <Semaphore x="2352492" class="Disease or Finding" value="Other Finding" score="0.58" ID="C36295">outcome </Semaphore>and causality of events was not reported.</narrativeincludeclinical>
				<sendercomment>Serious spontaneous report,

Oedema peripheral, Adverse drug reaction [hospitalisation], Lymphoedema [medically significant], assessed as unlisted according to the Core Data Sheet.

The information provided in this individual case does not warrant a change to the Core Data Sheet text. The topic will be monitored closely.

All spontaneous reports are considered suspected for reporting purposes or in accordance with national regulatory requirements.

Based on  Review of available reported data does not allow for a proper causality assessment. Reported events are unassessable.</sendercomment>
			</summary>
		</patient>
	</safetyreport>
</ichicsr></original></faers>